Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 591

1.

Human Immunodeficiency Virus Infection and Incident Atrial Fibrillation.

Sardana M, Hsue PY, Tseng ZH, Vittinghoff E, Nah G, Dewland TA, Marcus GM.

J Am Coll Cardiol. 2019 Sep 17;74(11):1512-1514. doi: 10.1016/j.jacc.2019.07.027. No abstract available.

PMID:
31514955
2.

Predictors for Blood Pressure Reduction in American Latinos: Secondary Analysis of the Adelgaza Program Data.

Li WW, Vittinghoff E, Fukuoka Y.

Hisp Health Care Int. 2019 Sep 11:1540415319869936. doi: 10.1177/1540415319869936. [Epub ahead of print]

PMID:
31505970
3.

Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk.

Kohli-Lynch CN, Bellows BK, Thanassoulis G, Zhang Y, Pletcher MJ, Vittinghoff E, Pencina MJ, Kazi D, Sniderman AD, Moran AE.

JAMA Cardiol. 2019 Aug 28. doi: 10.1001/jamacardio.2019.2851. [Epub ahead of print]

PMID:
31461121
4.

Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial.

Lown EA, Banerjee A, Vittinghoff E, Dvorak CC, Hartogensis W, Melton A, Mangurian C, Hu H, Shear D, Adcock R, Morgan M, Golden C, Hecht FM.

Glob Adv Health Med. 2019 Aug 14;8:2164956119870444. doi: 10.1177/2164956119870444. eCollection 2019.

5.

Applying machine learning to predict future adherence to physical activity programs.

Zhou M, Fukuoka Y, Goldberg K, Vittinghoff E, Aswani A.

BMC Med Inform Decis Mak. 2019 Aug 22;19(1):169. doi: 10.1186/s12911-019-0890-0.

6.

Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics.

Scott HM, Spinelli M, Vittinghoff E, Morehead-Gee A, Hirozawa A, James C, Hammer H, Liu A, Gandhi M, Buchbinder S.

AIDS. 2019 Aug 20. doi: 10.1097/QAD.0000000000002347. [Epub ahead of print]

PMID:
31436610
7.

Follow-up of incidental pulmonary nodules and association with mortality in a safety-net cohort.

Lee JS, Lisker S, Vittinghoff E, Cherian R, McCoy DB, Rybkin A, Su G, Sarkar U.

Diagnosis (Berl). 2019 May 9. pii: /j/dx.ahead-of-print/dx-2019-0008/dx-2019-0008.xml. doi: 10.1515/dx-2019-0008. [Epub ahead of print]

PMID:
31373897
8.

Home-based tuberculosis contact investigation in Uganda: a household randomised trial.

Davis JL, Turimumahoro P, Meyer AJ, Ayakaka I, Ochom E, Ggita J, Mark D, Babirye D, Okello DA, Mugabe F, Fair E, Vittinghoff E, Armstrong-Hough M, Dowdy D, Cattamanchi A, Haberer JE, Katamba A.

ERJ Open Res. 2019 Jul 29;5(3). pii: 00112-2019. doi: 10.1183/23120541.00112-2019. eCollection 2019 Jul.

9.

Development and Validation of the Personalized Sexual Health Promotion (SexPro) HIV Risk Prediction Model for Men Who Have Sex with Men in the United States.

Scott H, Vittinghoff E, Irvin R, Liu A, Nelson L, Del Rio C, Magnus M, Mannheimer S, Fields S, Van Tieu H, Kuo I, Shoptaw S, Grinsztejn B, Sanchez J, Wakefield S, Fuchs JD, Wheeler D, Mayer KH, Koblin BA, Buchbinder S.

AIDS Behav. 2019 Jul 27. doi: 10.1007/s10461-019-02616-3. [Epub ahead of print]

PMID:
31352633
10.

Housing First: Unsuppressed Viral Load Among Women Living with HIV in San Francisco.

Riley ED, Vittinghoff E, Koss CA, Christopoulos KA, Clemenzi-Allen A, Dilworth SE, Carrico AW.

AIDS Behav. 2019 Jul 19. doi: 10.1007/s10461-019-02601-w. [Epub ahead of print]

PMID:
31324996
11.

Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events.

Zhang Y, Vittinghoff E, Pletcher MJ, Allen NB, Zeki Al Hazzouri A, Yaffe K, Balte PP, Alonso A, Newman AB, Ives DG, Rana JS, Lloyd-Jones D, Vasan RS, Bibbins-Domingo K, Gooding HC, de Ferranti SD, Oelsner EC, Moran AE.

J Am Coll Cardiol. 2019 Jul 23;74(3):330-341. doi: 10.1016/j.jacc.2019.03.529.

12.

Real-world heart rate norms in the Health eHeart study.

Avram R, Tison GH, Aschbacher K, Kuhar P, Vittinghoff E, Butzner M, Runge R, Wu N, Pletcher MJ, Marcus GM, Olgin J.

NPJ Digit Med. 2019 Jun 25;2:58. doi: 10.1038/s41746-019-0134-9. eCollection 2019.

13.

Refining the World Health Organization Definition.

Tseng ZH, Salazar JW, Olgin JE, Ursell PC, Kim AS, Bedigian A, Probert J, Hart AP, Moffatt E, Vittinghoff E.

Circ Arrhythm Electrophysiol. 2019 Jul;12(7):e007171. doi: 10.1161/CIRCEP.119.007171. Epub 2019 Jun 28.

PMID:
31248279
14.

Effectiveness and cost of organized outreach for colorectal cancer screening: A Randomized Controlled Trial.

Somsouk M, Rachocki C, Mannalithara A, Garcia D, Laleau V, Grimes B, Issaka RB, Chen E, Vittinghoff E, Shapiro JA, Ladabaum U.

J Natl Cancer Inst. 2019 Jun 12. pii: djz110. doi: 10.1093/jnci/djz110. [Epub ahead of print]

PMID:
31187126
15.

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.

Coffin PO, Santos GM, Behar E, Hern J, Walker J, Matheson T, Kinnard EN, Silvis J, Vittinghoff E, Fox R, Page K.

PLoS One. 2019 Jun 3;14(6):e0217471. doi: 10.1371/journal.pone.0217471. eCollection 2019.

16.

Increasing Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease Among Hospitalized Adults in the United States.

Hirode G, Vittinghoff E, Wong RJ.

J Clin Gastroenterol. 2019 May 22. doi: 10.1097/MCG.0000000000001229. [Epub ahead of print]

PMID:
31135632
17.
18.

Risk Factors Associated With Atrioventricular Block.

Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ, Kenttä TV, Rissanen H, Vittinghoff E, Knekt P, Heliövaara M, Huikuri HV, Marcus GM.

JAMA Netw Open. 2019 May 3;2(5):e194176. doi: 10.1001/jamanetworkopen.2019.4176.

19.

Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.

Sharpton SR, Maraj B, Harding-Theobald E, Vittinghoff E, Terrault NA.

Am J Clin Nutr. 2019 May 24. pii: nqz042. doi: 10.1093/ajcn/nqz042. [Epub ahead of print]

PMID:
31124558
20.

Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.

Spinelli MA, Glidden DV, Anderson PL, Gandhi M, Cohen S, Vittinghoff E, Coleman ME, Scott H, Bacon O, Elion R, Kolber MA, Buchbinder SP, Liu AY.

J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):158-162. doi: 10.1097/QAI.0000000000002005.

PMID:
31095005
21.

Does cannabis legalisation change healthcare utilisation? A population-based study using the healthcare cost and utilisation project in Colorado, USA.

Delling FN, Vittinghoff E, Dewland TA, Pletcher MJ, Olgin JE, Nah G, Aschbacher K, Fang CD, Lee ES, Fan SM, Kazi DS, Marcus GM.

BMJ Open. 2019 May 15;9(5):e027432. doi: 10.1136/bmjopen-2018-027432.

22.

Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!

Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C.

Eur Respir J. 2019 May 9;53(5). pii: 1900615. doi: 10.1183/13993003.00615-2019. Print 2019 May. No abstract available.

PMID:
31072878
23.

Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network.

Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Gonzalez R, Morehead-Gee A, Gandhi M, Buchbinder SP.

Open Forum Infect Dis. 2019 Feb 26;6(4):ofz101. doi: 10.1093/ofid/ofz101. eCollection 2019 Apr.

24.

The association of religious affiliation with cholesterol levels among South Asians: the Mediators of Atherosclerosis in South Asians Living in America study.

Hirode G, Vittinghoff E, Bharmal NH, Kandula NR, Kanaya AM.

BMC Cardiovasc Disord. 2019 Mar 29;19(1):75. doi: 10.1186/s12872-019-1045-z.

25.

NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure.

Whitman IR, Vittinghoff E, DeFilippi CR, Gottdiener JS, Alonso A, Psaty BM, Heckbert SR, Hoogeveen RC, Arking DE, Selvin E, Chen LY, Dewland TA, Marcus GM.

J Am Heart Assoc. 2019 Apr 2;8(7):e010868. doi: 10.1161/JAHA.118.010868.

26.

Design and recruitment of the randomized order safety trial evaluating resident-physician schedules (ROSTERS) study.

Blackwell T, Kriesel DR, Vittinghoff E, O'Brien CS, Sullivan JP, Viyaran NC, Rahman SA, Lockley SW, Barger LK, Halbower AC, Poynter SE, Wright KP Jr, Yu PL, Zee PC, Landrigan CP, Czeisler CA, Stone KL; ROSTERS Study Group.

Contemp Clin Trials. 2019 May;80:22-33. doi: 10.1016/j.cct.2019.03.005. Epub 2019 Mar 15.

PMID:
30885799
27.

Relation of Pregnancy Loss to Risk of Cardiovascular Disease in Parous Postmenopausal Women (From the Women's Health Initiative).

Hall PS, Nah G, Vittinghoff E, Parker DR, Manson JE, Howard BV, Sarto GE, Gass ML, Sealy-Jefferson SM, Salmoirago-Blotcher E, Stefanick ML, Shadyab AH, Van Horn LV, Park K, Parikh NI.

Am J Cardiol. 2019 May 15;123(10):1620-1625. doi: 10.1016/j.amjcard.2019.02.012. Epub 2019 Feb 22.

PMID:
30871746
28.

High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking Application.

Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Coleman K, Buchbinder SP.

Sex Transm Dis. 2019 Apr;46(4):e32-e34. doi: 10.1097/OLQ.0000000000000942.

PMID:
30870327
29.

Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.

Hirode G, Vittinghoff E, Wong RJ.

Dig Dis Sci. 2019 Jun;64(6):1448-1457. doi: 10.1007/s10620-019-05576-9. Epub 2019 Mar 13.

PMID:
30863953
30.

Predictors of atrial ectopy and their relationship to atrial fibrillation risk.

Kerola T, Dewland TA, Vittinghoff E, Heckbert SR, Stein PK, Marcus GM.

Europace. 2019 Jun 1;21(6):864-870. doi: 10.1093/europace/euz008.

PMID:
30843034
31.

Cluster randomized trial of a patient-centered contraceptive decision support tool, My Birth Control.

Dehlendorf C, Fitzpatrick J, Fox E, Holt K, Vittinghoff E, Reed R, Campora MP, Sokoloff A, Kuppermann M.

Am J Obstet Gynecol. 2019 Jun;220(6):565.e1-565.e12. doi: 10.1016/j.ajog.2019.02.015. Epub 2019 Feb 11.

PMID:
30763545
32.

Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumonia.

Tanizawa K, Ley B, Vittinghoff E, Elicker BM, Henry TS, Wolters PJ, Brownell R, Liu S, Collard HR, Jones KD.

Histopathology. 2019 Jun;74(7):1088-1097. doi: 10.1111/his.13840. Epub 2019 Apr 25.

PMID:
30742318
33.

Alcohol consumption and leukocyte telomere length.

Dixit S, Whooley MA, Vittinghoff E, Roberts JD, Heckbert SR, Fitzpatrick AL, Lin J, Leung C, Mukamal KJ, Marcus GM.

Sci Rep. 2019 Feb 5;9(1):1404. doi: 10.1038/s41598-019-38904-0.

34.

National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States.

Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA.

JAMA Intern Med. 2019 Mar 1;179(3):340-348. doi: 10.1001/jamainternmed.2018.6536.

35.

Access to Federally Qualified Health Centers and Emergency Department Use Among Uninsured and Medicaid-insured Adults: California, 2005 to 2013.

Nath JB, Costigan S, Lin F, Vittinghoff E, Hsia RY.

Acad Emerg Med. 2019 Feb;26(2):129-139. doi: 10.1111/acem.13494. Epub 2019 Jan 16.

PMID:
30648780
36.

Incidence and Progression of Coronary Artery Calcium in South Asians Compared With 4 Race/Ethnic Groups.

Kanaya AM, Vittinghoff E, Lin F, Kandula NR, Herrington D, Liu K, Blaha M, Budoff MJ.

J Am Heart Assoc. 2019 Jan 22;8(2):e011053. doi: 10.1161/JAHA.118.011053.

37.

A group-based yoga program for urinary incontinence in ambulatory women: feasibility, tolerability, and change in incontinence frequency over 3 months in a single-center randomized trial.

Huang AJ, Chesney M, Lisha N, Vittinghoff E, Schembri M, Pawlowsky S, Hsu A, Subak L.

Am J Obstet Gynecol. 2019 Jan;220(1):87.e1-87.e13. doi: 10.1016/j.ajog.2018.10.031. Epub 2018 Oct 26.

PMID:
30595143
38.

The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study.

Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C.

Eur Respir J. 2019 Mar 7;53(3). pii: 1801587. doi: 10.1183/13993003.01587-2018. Print 2019 Mar.

PMID:
30578385
39.

Modifiable Predictors of Ventricular Ectopy in the Community.

Kerola T, Dewland TA, Vittinghoff E, Heckbert SR, Stein PK, Marcus GM.

J Am Heart Assoc. 2018 Nov 20;7(22):e010078. doi: 10.1161/JAHA.118.010078.

40.

Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.

Lee BP, Vittinghoff E, Hsu C, Han H, Therapondos G, Fix OK, Victor DW, Dronamraju D, Im GY, Voigt MD, Rice JP, Lucey MR, Eswaran S, Chen PH, Li Z, Maddur H, Terrault NA.

Hepatology. 2019 Apr;69(4):1477-1487. doi: 10.1002/hep.30478. Epub 2019 Mar 5.

PMID:
30561766
41.

Use of a pooled cohort to impute cardiovascular disease risk factors across the adult life course.

Zeki Al Hazzouri A, Vittinghoff E, Zhang Y, Pletcher MJ, Moran AE, Bibbins-Domingo K, Golden SH, Yaffe K.

Int J Epidemiol. 2019 Jun 1;48(3):1004-1013. doi: 10.1093/ije/dyy264.

PMID:
30535320
42.

Boys, Bulk, and Body Ideals: Sex Differences in Weight-Gain Attempts Among Adolescents in the United States.

Nagata JM, Bibbins-Domingo K, Garber AK, Griffiths S, Vittinghoff E, Murray SB.

J Adolesc Health. 2019 Apr;64(4):450-453. doi: 10.1016/j.jadohealth.2018.09.002. Epub 2018 Oct 25.

PMID:
30482658
43.

Systematic Multi-Domain Alzheimer's Risk Reduction Trial (SMARRT): Study Protocol.

Yaffe K, Barnes DE, Rosenberg D, Dublin S, Kaup AR, Ludman EJ, Vittinghoff E, Peltz CB, Renz AD, Adams KJ, Larson EB.

J Alzheimers Dis. 2019;70(s1):S207-S220. doi: 10.3233/JAD-180634.

44.
45.

Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women.

Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D.

Menopause. 2018 Nov;25(11):1286-1290. doi: 10.1097/GME.0000000000001230.

PMID:
30358724
46.

Wearable Cardioverter-Defibrillator after Myocardial Infarction.

Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK; VEST Investigators.

N Engl J Med. 2018 Sep 27;379(13):1205-1215. doi: 10.1056/NEJMoa1800781.

47.

Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.

Hessol NA, Whittemore H, Vittinghoff E, Hsu LC, Ma D, Scheer S, Schwarcz SK.

Lancet HIV. 2018 Nov;5(11):e647-e655. doi: 10.1016/S2352-3018(18)30179-6. Epub 2018 Sep 21.

PMID:
30245004
48.

Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study.

Liu AY, Vittinghoff E, von Felten P, Rivet Amico K, Anderson PL, Lester R, Andrew E, Estes I, Serrano P, Brothers J, Buchbinder S, Hosek S, Fuchs JD.

Clin Infect Dis. 2019 May 30;68(12):2010-2017. doi: 10.1093/cid/ciy810.

49.

No one to turn to: low social support and the incidence of undesired pregnancy in the United States.

Moseson H, Dehlendorf C, Gerdts C, Vittinghoff E, Hiatt RA, Barber J.

Contraception. 2018 Oct;98(4):275-280. doi: 10.1016/j.contraception.2018.06.009. Epub 2018 Jul 2.

PMID:
30220308
50.

Response.

Johannson KA, Vittinghoff E, Morisset J, Wolters PJ, Noth EM, Balmes JR, Collard HR.

Chest. 2018 Sep;154(3):727-728. doi: 10.1016/j.chest.2018.05.042. No abstract available.

PMID:
30195362

Supplemental Content

Loading ...
Support Center